Copyright
©The Author(s) 1999.
World J Gastroenterol. Oct 15, 1999; 5(5): 408-416
Published online Oct 15, 1999. doi: 10.3748/wjg.v5.i5.408
Published online Oct 15, 1999. doi: 10.3748/wjg.v5.i5.408
Table 7 Expression of gastrin, c-myc, c-fos, rasp21 and AgNORs in different pathological carcinoma tissue
| Group | n | Gastrin positive (%) | c-myc positive (%) | c-fos positive (%) | rasp21 positive (%) | AgNORs |
| Highly-differentiated | 26 | 14 (53.9)a | 15 (57.7) | 13 (50.0) | 15 (57.7) | 7.12 ± 1.80 |
| Moderately-differentiated | 12 | 4 (33.3) | 5 (41.7) | 7 (58.3) | 6 (50.0) | 7.25 ± 0.86 |
| Poorly- and mucinous | 10 | 1 (10.0) | 6 (60.0) | 3 (30.0) | 5 (50.0) | 7.11 ± 1.20 |
- Citation: He SW, Shen KQ, He YJ, Xie B, Zhao YM. Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma. World J Gastroenterol 1999; 5(5): 408-416
- URL: https://www.wjgnet.com/1007-9327/full/v5/i5/408.htm
- DOI: https://dx.doi.org/10.3748/wjg.v5.i5.408